Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-28

Clinical Trial Update: A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating prednisolone, itraconazole, or their combination for Allergic Bronchopulmonary Aspergillosis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Itraconazole (Itraconazole)
  • Prednisolone (Prednisolone)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Allergic Bronchopulmonary Aspergillosis | Phase 3 | Status: RECRUITING